JSPR - Jasper Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
34,627
34,627
25,421
15,883
Selling general and administrative
16,569
16,569
11,412
4,800
Total operating expenses
51,196
51,196
36,833
20,683
Operating income or loss
-51,196
-51,196
-36,833
-20,683
Total other income/expenses net
13,511
13,511
6,196
-10,986
Income before tax
-37,685
-37,685
-30,637
-31,669
Income from continuing operations
-37,685
-37,685
-30,637
-31,669
Net income
-37,685
-37,685
-30,637
-31,669
Net income available to common shareholders
-37,685
-37,685
-30,637
-31,669
Basic EPS
-
-1.03
-2.69
-0.84
Diluted EPS
-
-1.03
-2.69
-0.84
Basic average shares
-
36,483
11,394
37,816
Diluted average shares
-
36,483
11,394
37,816
EBITDA
-
-51,196
-36,833
-20,683